Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis

SIMPLE SUMMARY: As clinical practice lacks direct data for head-to-head comparisons across targeted combination approaches, we performed a Bayesian network meta-analysis to indirectly analyze the efficacy and safety of various combination therapies. A total of 12 modes of combination TKI therapy are...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Jianchao, Li, Bowen, Wang, Yadong, Huang, Zhicheng, Liu, Xinyu, Guo, Chao, Zheng, Zhibo, Liang, Naixin, Le, Xiuning, Li, Shanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563574/
https://www.ncbi.nlm.nih.gov/pubmed/36230817
http://dx.doi.org/10.3390/cancers14194894

Ejemplares similares

Ejemplares similares